Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study

被引：0
|
作者：
Abdullah M. Alguwaihes
机构：
[1] King Saud University,Department of Internal Medicine, College of Medicine
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Dapagliflozin; Diabetic ketoacidosis; HbA1c; Post-authorization safety study; Saudi Arabia; SGLT2 inhibitor; T2DM; Urinary tract infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1979 / 1992
页数：13
相关论文
共 50 条
  • [41] Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus - a phase 4 study in India
    Wangnoo, S. K.
    Bhadada, Sanjay Kumar
    Farishta, Faraz
    Naidu, Girithara Gopalakrishnan Jayaram
    Pattnaik, Indira
    Manohar, K. N.
    Singh, K. P.
    Gupta, Sandeep Kumar
    Bharath, H. S.
    Ghosh, Sujoy
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [42] Phenotypical evaluation of lymphocytes and monocytes in patients with type 2 diabetes mellitus in Saudi Arabia
    Allahyani, Mamdouh
    Alshalawi, Amani M.
    Alshalawii, Maram R.
    Alqorashi, Shahad A.
    Aljuaid, Abdulelah
    Almehmadi, Mazen M.
    Bokhary, Mohammed A.
    Albrgey, Alhanouf S.
    Alghamdi, Ahmad A.
    Aldairi, Abdullah F.
    Alhazmi, Ayman S.
    SAUDI MEDICAL JOURNAL, 2023, 44 (03) : 296 - 305
  • [43] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
  • [44] Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Feng, Miao
    Lv, Haihong
    Xu, Xia
    Wang, Jue
    Lyu, Wenyi
    Fu, Songbo
    MEDICINE, 2019, 98 (30)
  • [45] Obesity and overweight in type II diabetes mellitus patients in Saudi Arabia
    Alzaid, AA
    SAUDI MEDICAL JOURNAL, 1999, 20 (11) : 899 - 899
  • [46] Obesity and overweight in Type II diabetes mellitus patients in Saudi Arabia
    El-Hazmi, MA
    Warsy, AS
    SAUDI MEDICAL JOURNAL, 1999, 20 (02) : 167 - 172
  • [47] Efficacy and Safety of Dapagliflozin in Patients with Inadequately Controlled Type 1 Diabetes-DEPICT-2 Study
    Mathieu, Chantal
    Dandona, Paresh
    Gillard, Pieter
    Senior, Peter A.
    Hasslacher, Christoph
    Araki, Eiichi
    Lind, Marcus
    Bain, Stephen C.
    Jabbour, Serge
    Arya, Niki
    Thoren, Fredrik A.
    Langkilde, Anna Maria
    DIABETES, 2018, 67
  • [48] Real-world safety of dapagliflozin in elderly patients with type 2 diabetes in China: post-hoc analysis of the DONATE study
    Guo, L.
    Wang, J.
    Li, L.
    Yuan, L.
    Chen, S.
    Wang, H.
    Li, T.
    Qi, L.
    Yang, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S278 - S279
  • [49] Safety of metformin in Type 2 diabetes mellitus
    Baigent, C
    Peto, R
    DIABETIC MEDICINE, 1999, 16 (02) : 89 - 90
  • [50] Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
    Dharmalingam, Mala
    Sharma, Surendra Kumar
    Prakash, Ved
    Maiti, Animesh
    Kumar, Ritesh
    Murthy, Laxminarayanappa Sreenivasa S.
    Ramanathan, Balamurugan
    Maheshwari, Sanjiv
    Kethavath, Sunil Naik
    Ogale, Dhananjay
    Bachubhai, Prajapati Vipul Kumar
    Sonawane, Ashutosh B.
    Shah, Vaishal
    Suresh, Manjula
    Chakraborty, Sisir
    Manjunath, Krishna Kumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
12345